|
Post by kball on May 21, 2015 15:35:18 GMT -5
There was mention (on ymb) in a post on the annual meeting from bio.bull that the factory tour guide (head of mfg i believe) relayed that the next techno candidate would be manufactured elsewhere as all 12 lines were earmarked for Afrezza production.
Can't vouch for authenticity, but i did find that informative if true
|
|
|
Post by esstan2001 on May 21, 2015 15:45:25 GMT -5
>>>>>>>>>>>>>>>>>>. There was mention (on ymb) in a post on the annual meeting from bio.bull that the factory tour guide (head of mfg i believe) relayed that the next techno candidate would be manufactured elsewhere as all 12 lines were earmarked for Afrezza production. Can't vouch for authenticity, but i did find that informative if true Read more: mnkd.proboards.com/posts/recent#ixzz3aoAy5ysI<<<<<<<<<<<<<<<<<< Well, all 'candidates' can be handled on premises in the 'prototypes' lab- they will make miniature lines, they have small versions of the large dehydrating / cryo / etc equipment... but past Phase 1-3, real production would have to happen elsewhere if Danbury is fully built out by then (all expansion space devoted to Afrezza lines)
|
|
|
Post by gomnkd on May 21, 2015 15:48:47 GMT -5
al mann made a joke, close to 400m diabetics our factory can only handle 2m what are the rest going to do lol so far, the joke is on us
|
|
|
Post by njguy on May 21, 2015 16:27:13 GMT -5
How can I upload a video file.I have one video clip when Al talked about the Spirometer issue.
I tried to add attachment but it has a limit of 1MB
|
|
|
Post by kc on May 21, 2015 16:29:29 GMT -5
YouTube with a link back to this page.
|
|
|
Post by njguy on May 21, 2015 16:35:47 GMT -5
No other way?? I didn't upload anything to youtube so far. I may need to create an account now. Trying to avoid that option. So far I was able to get it from my iphone to my PC via email (video quality got downgraded in the process as I emailed it)
If youtube is the only option, I'll try to do it later tonight.
|
|
|
Post by mnholdem on May 21, 2015 16:59:39 GMT -5
al mann made a joke, close to 400m diabetics our factory can only handle 2m what are the rest going to do lol so far, the joke is on us I don't read Al's remark as a joke at all, but as a statement of extreme confidence that Afrezza will be widely accepted. That's a leadership quality I hope Hakan is able to develop.
|
|
|
Post by njguy on May 21, 2015 17:21:37 GMT -5
|
|
|
Post by dstevenson on May 21, 2015 17:48:38 GMT -5
Thanks for the clip
|
|
|
Post by od on May 21, 2015 18:39:29 GMT -5
Thanks for the video. I have shared before that I believe we will look back on the spirometry noise as a distracting rabbit hole. Today, however, it is impacting sales, and I am glad SNY and MNKD are paying attention to the issue. With the caveat that I could not clearly see the device presented, it appeared that it was an FEV1 only meter. The device is fine to clear the black box hurdle, but unless reimbursement requirements have been modified in the past three months, third parties will not reimburse for FEV1 only and the cost of the meter will not be covered with one test. Knowing how important Afrezza is, if I was a provider I would spend the $50.00 knowing it was in the best interest of my patients, and not get hung up on reimbursement. On the other hand I might spend the $500.00 - $1000.00 for a full spirometer and get reimbursed for appropriate use with a broad patient base - everything I read indicates it would pay for itself quickly.
|
|
|
Post by 1 percenter on May 21, 2015 18:42:33 GMT -5
Thanks for the video. I have shared before that I believe we will look back on the spirometry noise as a distracting rabbit hole. Today, however, it is impacting sales, and I am glad SNY and MNKD are paying attention to the issue. With the caveat that I could not clearly see the device presented, it appeared that it was an FEV1 only meter. The device is fine to clear the black box hurdle, but unless reimbursement requirements have been modified in the past three months, third parties will not reimburse for FEV1 only and the cost of the meter will not be covered with one test. Knowing how important Afrezza is, if I was a provider I would spend the $50.00 knowing it was in the best interest of my patients, and not get hung up on reimbursement. On the other hand I might spend the $500.00 - $1000.00 for a full spirometer and get reimbursed for appropriate use with a broad patient base - everything I read indicates it would pay for itself quickly. One problem. You have to be a doctor that is willing to prescribe the drug. If you are one of the, "my patients have good control so no need to put them on a new and controversial med, so no need to invest in a new device regardless of cost," there goes that plan.
|
|
|
Post by liane on May 21, 2015 18:46:07 GMT -5
OMG. Now THAT is one cliffhanger …... Sorry for the cliffhanger... A lot of what I was going to add has been covered in this and the other meeting thread (thanks everyone for chiming in). Several in the audience did raise the questions of lack of positive communication from management, insider selling, low script counts, what is Sanofi doing to market Afrezza, short seller manipulation, and the low share price. The points were very well made and very impassioned. They communicated clearly to management that shareholders are very concerned and want answers. I think for their part, management conveyed what info they could. There was a request from one shareholder that the board should consider creating a new Corporate Communications position. They said they would look into that. The tour was awesome! The do have the one "prototype" line. It's a smaller scale of their other 3 regular lines. This is what was used to make the TI for the clinical trials. It is also what could be used to develop new drugs on Technosphere platform. As one of our other posters noted, the actual manufacture of other drugs would probably be elsewhere to avoid cross-contamination.
|
|
|
Post by eddiemoy on May 21, 2015 21:11:58 GMT -5
they are doing their research for TI product pipeline across the street in building 8.
|
|
|
Post by als57 on May 22, 2015 8:28:03 GMT -5
Once again Hakan either misinterperted the question about Exubura having the same FDA requirement of the spirometer test or he was dancing saying that wasn't the reason that Exubura failed.
We all know that, Hakan try saying Bong! I'm undecided as to if he lives in a different world or he's a " dancer."
|
|
|
Post by thekindaguyiyam on May 24, 2015 11:28:49 GMT -5
so far, the joke is on us I don't read Al's remark as a joke at all, but as a statement of extreme confidence that Afrezza will be widely accepted. That's a leadership quality I hope Hakan is able to develop. I see it as a light hearted way to say we have this capacity of production now; and expansion will be necessary. I do not see it as a joke on the shareholder or the patients using afrezza; I see it as a subtle reference to support confidence that we are going to need to get bigger production lines out there.
|
|